Himalaya Nutravedics IPO 2026: Himalaya Nutravedics India’s SME IPO is getting a lot of notice before it opens on September 22. The firm plans to collect about ₹26.5 crore through the share sale. It also wants the shares to be traded on the BSE SME platform.
More news is now out on the Himalaya Nutravedics IPO, including the GMP, the price range, allotment details, the listing day and the possible gain after listing.
Vivekanand Cotspin IPO: Check GMP, Issue Price, Lot Size and Dates
The Himalaya Nutravedics IPO GMP is currently ₹0, according to the latest available grey-market tracking data.
At a GMP of ₹0, the indicative listing price would be around the issue price, meaning there is currently no unofficial premium being indicated by the grey market.
However, GMP is an unofficial and unregulated indicator. It can change quickly before listing and should not be treated as a guaranteed listing price or return.
Veegaland Developers IPO Allotment Status 2026 on BSE, NSE, MUFG Intime
Since the current GMP is ₹0, the latest grey market figures do not point to any rise on listing.
For instance, using the top IPO price of ₹106:
Still, the listing price may end up different. GMP is not the same thing as the final price set on the exchange.
A clearer profit view will only come after more details are out. These include the subscription status, the move in GMP, and the final issue price.
Horizon Industrial Parks IPO Day 3: GMP, Subscription Status, Allotment Date, Should You Subscribe?
The company has not shared the final date for allotment yet. Once the basis of allotment is set, investors can see their application status via the IPO registrar. They can also use the exchange linked portal, if available.
The proposed listing date is September 29, 2026.
Himalaya Nutravedics India works in Ayurvedic and nutraceutical products. Its activities cover contract manufacturing, licensing under loans, and marketing under its own brands.
On its official site, the company says it blends older Ayurveda with newer product development. It also points to certifications and approvals. These include FSSAI certification, AYUSH approval, and ISO 9001:2015.
The company sells products in multiple categories. It has also been building its reach in the Ayurvedic and nutraceutical space.
Jio IPO 2026: Timeline, Size, Valuation and Key Details
Recent IPO notes say total income went up from about ₹21 crore in FY25 to about ₹43 crore in FY26. Net profit after tax also rose, from roughly ₹2.23 crore to about ₹7.39 crore.
Looking at the numbers, that is around 105% growth in revenue and about 231% growth in profit in FY26.
Many investors will likely keep an eye on these earnings moves. They will watch this as the IPO valuation is discussed.
This website uses cookies.